Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough. Exubera was also recognized as the most innovative diabetes medicine of 2006 in Germany.
|Traded as||NASDAQ: NKTR S&P 600 Component|
|Revenue||$148.92 million (As of 2013)|
|Headquarters||San Francisco, California|
NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.
It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.
The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.
Net Promoter Score is a number from -100 from 100.
Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.
The industry average for Health Care / Major Pharmaceuticals is 0.
The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.
Consider an example: If Nektar Therapeutics sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.
On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.
Therefore, comparing the NPS score of Nektar Therapeutics with your own without any further context is not that useful.
What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.
|Comcast||Consumer Brands / Car Manufacturers||-3|
|Telfort||Telecommunications / Wireless Carrier||-3|
|Ocado||Consumer Brands / Grocery||-4|
|Time Warner Cable||Telecommunications / Cable/TV service||-5|
|BBC||Media / Cable/TV service||-5|
|Sky||Telecommunications / Cable/TV service||-5|
|Time Warner||Telecommunications / Cable/TV service||-5|
|CIGNA||Insurance / Health and Life Insurance||-1|
|Vodafone||Telecommunications / Wireless Carrier||-1|
|Chase||Financial Services / Banking||-1|
We have estimated the Net Promoter Score of Nektar Therapeutics based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.